Physician profile
Vanessa Kes
NPI 1811592181
$2,291.63
in general payments reported to CMS, 2019-2025
17 companies · $1,023 in 2025
The $1,023 reported for 2025 was more than what 97% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $207 · 2022: $467 · 2023: $583 · 2024: $11.36 · 2025: $1,023.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $805 · Food and Beverage: $776 · Education: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $805.15 |
| Food and Beverage | $775.95 |
| Education | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,035.15 | 2022-2025 | Interstim |
| Mayne Pharma Commercial LLC | $372.24 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $150.94 | 2023 | Myfembree |
| Astellas Pharma US INC | $114.78 | 2023 | Veozah |
| Novo Nordisk INC | $110.02 | 2021 | |
| Abbvie INC. | $107.07 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.87 | 2021-2023 | |
| Shield Therapeutics INC | $63.04 | 2022-2023 | Accrufer |
| Pfizer INC. | $58.74 | 2021-2022 | |
| Organon LLC | $46.28 | 2021-2023 | Nexplanon |
| Evofem Biosciences, INC. | $28.63 | 2022 | |
| Scynexis, INC. | $27.31 | 2022 | |
| Myovant Sciences INC. | $23.04 | 2022 | |
| Avion Pharmaceuticals | $14.86 | 2022 | |
| Amgen INC. | $14.44 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $14.20 | 2021 | |
| Therapeuticsmd, INC. | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Kes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.